Advertisement

Advertisement

Home / Health / Flu-Fighting Freedom: FluMist Offers Convenient At-Home Vaccination Option

Flu-Fighting Freedom: FluMist Offers Convenient At-Home Vaccination Option

Summary

  • FluMist, the only FDA-approved nasal spray flu vaccine, now available for self-administration
  • FluMist Home delivery service launching in 34 states for 2025-2026 flu season
  • Vaccine is free under most commercial insurance, with $8.99 shipping fee
Flu-Fighting Freedom: FluMist Offers Convenient At-Home Vaccination Option

As the 2025-2026 flu season approaches, those looking to protect themselves have a new at-home option. FluMist, the only nasal spray flu vaccine approved by the FDA, is now available for self-administration through a new delivery service called FluMist Home.

Launched just last month, FluMist Home will be available in 34 states this flu season. Customers can order the same FluMist nasal spray that is administered in doctor's offices and pharmacies, and have it shipped directly to their homes. The vaccine is free under most commercial insurance plans, though there is a $8.99 fee for shipping and processing.

To order FluMist Home, customers must provide basic personal, medical, and insurance information. The service is approved for use by those aged 2 to 49, though a caregiver should administer the vaccine to individuals between 2 and 17 years old. The website includes detailed instructions on how to properly administer the nasal spray.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Advertisement

Advertisement

FAQ

FluMist is the only FDA-approved nasal spray flu vaccine, which can now be self-administered through a new home delivery service.
FluMist Home will be available in 34 states for the 2025-2026 flu season, including Alabama, Arizona, California, and more.
FluMist is free under most commercial insurance plans, but there is a $8.99 fee for shipping and processing.

Read more news on